HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED

Clinical trials for HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED explained in plain language.

Never miss a new study

Get alerted when new HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED trials appear

Sign up with your email to follow new studies for HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Elderly breast cancer study pulled before it began

Disease control Terminated

This study aimed to test the safety and effectiveness of adding the drug ribociclib to standard hormone therapy and radiation for women aged 70 and older with a certain type of breast cancer. The participants would have been newly diagnosed and unable or unwilling to have surgery…

Matched conditions: HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED

Phase: PHASE1, PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control

Last updated May 22, 2026 13:53 UTC

HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED

Get alerted when new HER2 NEGATIVE BREAST CANCER NOT IMMEDIATELY OPERATED trials appear

Elderly breast cancer study pulled before it began